Martin, G.; Lee, K.Y.; Roberts, C.; Zheng, J.; Batth, G.K.; Dalleywater, W.; Khanim, F.L.; Oltean, S.; Gaston, K.; Jayaraman, P.-S.
Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model. Cancers 2025, 17, 3721.
https://doi.org/10.3390/cancers17223721
AMA Style
Martin G, Lee KY, Roberts C, Zheng J, Batth GK, Dalleywater W, Khanim FL, Oltean S, Gaston K, Jayaraman P-S.
Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model. Cancers. 2025; 17(22):3721.
https://doi.org/10.3390/cancers17223721
Chicago/Turabian Style
Martin, Grace, Ka Ying Lee, Christopher Roberts, Jinxia Zheng, Gagan Kaur Batth, William Dalleywater, Farhat Latif Khanim, Sebastian Oltean, Kevin Gaston, and Padma-Sheela Jayaraman.
2025. "Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model" Cancers 17, no. 22: 3721.
https://doi.org/10.3390/cancers17223721
APA Style
Martin, G., Lee, K. Y., Roberts, C., Zheng, J., Batth, G. K., Dalleywater, W., Khanim, F. L., Oltean, S., Gaston, K., & Jayaraman, P.-S.
(2025). Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model. Cancers, 17(22), 3721.
https://doi.org/10.3390/cancers17223721
